Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 1
1975 1
1978 1
1980 1
1981 2
1984 4
1985 4
1986 1
1987 1
1988 2
1989 3
1990 4
1991 2
1992 3
1993 5
1994 3
1995 4
1996 3
1997 9
1998 8
1999 7
2000 7
2001 11
2002 6
2003 13
2004 8
2005 10
2006 5
2007 11
2008 13
2009 11
2010 12
2011 17
2012 22
2013 14
2014 9
2015 24
2016 14
2017 17
2018 17
2019 10
2020 15
2021 15
2022 18
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
Morizane C, Machida N, Honma Y, Okusaka T, Boku N, Kato K, Nomura S, Hiraoka N, Sekine S, Taniguchi H, Okano N, Yamaguchi K, Sato T, Ikeda M, Mizuno N, Ozaka M, Kataoka T, Ueno M, Kitagawa Y, Terashima M, Furuse J; Japan Clinical Oncology Group (JCOG). Morizane C, et al. Among authors: ikeda m. JAMA Oncol. 2022 Oct 1;8(10):1447-1455. doi: 10.1001/jamaoncol.2022.3395. JAMA Oncol. 2022. PMID: 35980649 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This open-label phase 3 randomized clinical trial enrolled chemotherapy-naive patients aged 20 to 75 years who had recurrent or unresectable NEC (according to the 2010 World Health Organization classification system) arising from the gast …
DESIGN, SETTING, AND PARTICIPANTS: This open-label phase 3 randomized clinical trial enrolled chemotherapy-naive patients aged 20 to 75 year …
Loss of Extreme Long-Range Enhancers in Human Neural Crest Drives a Craniofacial Disorder.
Long HK, Osterwalder M, Welsh IC, Hansen K, Davies JOJ, Liu YE, Koska M, Adams AT, Aho R, Arora N, Ikeda K, Williams RM, Sauka-Spengler T, Porteus MH, Mohun T, Dickel DE, Swigut T, Hughes JR, Higgs DR, Visel A, Selleri L, Wysocka J. Long HK, et al. Among authors: ikeda k. Cell Stem Cell. 2020 Nov 5;27(5):765-783.e14. doi: 10.1016/j.stem.2020.09.001. Epub 2020 Sep 28. Cell Stem Cell. 2020. PMID: 32991838 Free PMC article.
Using mouse models, we demonstrate that PRS phenotypic specificity arises from the convergence of two mechanisms: confinement of Sox9 dosage perturbation to developing facial structures through context-specific enhancer activity and heightened sensitivity of the lower jaw …
Using mouse models, we demonstrate that PRS phenotypic specificity arises from the convergence of two mechanisms: confinement of Sox9 …
The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis.
Ikeda N, Kubota H, Suzuki R, Morita M, Yoshimura A, Osada Y, Kishida K, Kitamura D, Iwata A, Yotsumoto S, Kurotaki D, Nishimura K, Nishiyama A, Tamura T, Kamatani T, Tsunoda T, Murakawa M, Asahina Y, Hayashi Y, Harada H, Harada Y, Yokota A, Hirai H, Seki T, Kuwahara M, Yamashita M, Shichino S, Tanaka M, Asano K. Ikeda N, et al. Cell Rep. 2023 Mar 28;42(3):112165. doi: 10.1016/j.celrep.2023.112165. Epub 2023 Feb 28. Cell Rep. 2023. PMID: 36862552 Free article.
In this study we find that Ym1(+)Ly6C(hi) monocytes, an immunoregulatory entity of neutrophil-like monocytes, arise from progenitors of neutrophil 1 (proNeu1). Granulocyte-colony stimulating factor (G-CSF) favors the production of neutrophil-like monocytes through previous …
In this study we find that Ym1(+)Ly6C(hi) monocytes, an immunoregulatory entity of neutrophil-like monocytes, arise from progenitors …
Lipid metabolic vulnerabilities of multiple myeloma.
Torcasio R, Gallo Cantafio ME, Ikeda RK, Ganino L, Viglietto G, Amodio N. Torcasio R, et al. Among authors: ikeda rk. Clin Exp Med. 2023 Nov;23(7):3373-3390. doi: 10.1007/s10238-023-01174-2. Epub 2023 Aug 28. Clin Exp Med. 2023. PMID: 37639069 Free PMC article. Review.
These findings will provide a new path to understanding the mechanisms underlying how lipid vulnerabilities may arise and affect the phenotype of malignant plasma cells, highlighting novel druggable pathways with a significant impact on the management of MM....
These findings will provide a new path to understanding the mechanisms underlying how lipid vulnerabilities may arise and affect the …
A medico-legal definition of femicide.
Cecchi R, Sassani M, Agugiaro G, Caroppo E, De Lellis P, Sannella A, Mazza M, Ikeda T, Kondo T, Masotti V. Cecchi R, et al. Among authors: ikeda t. Leg Med (Tokyo). 2022 Nov;59:102101. doi: 10.1016/j.legalmed.2022.102101. Epub 2022 Jun 21. Leg Med (Tokyo). 2022. PMID: 35763984 Review.
Additionally, a non-homogeneous framing of the term femicide arises from the forensic pathology literature and national laws. Starting from one of the funding principle of medical ethics - autonomy - authors propose to define femicide as a murder perpetrated because of a f …
Additionally, a non-homogeneous framing of the term femicide arises from the forensic pathology literature and national laws. Startin …
Surgery for Thyroid Cancer Invading the Trachea.
Tsutsui H, Tamura A, Ito J, Ohara R, Hoshi M, Kubota M, Yano Y, Ikeda N. Tsutsui H, et al. Among authors: ikeda n. Indian J Surg Oncol. 2022 Mar;13(1):184-190. doi: 10.1007/s13193-021-01466-7. Epub 2021 Oct 27. Indian J Surg Oncol. 2022. PMID: 35462665 Free PMC article. Review.
The treatment plan for thyroid cancer is determined based on the site, depth, and extent of the invasion. Different from tumours arising from the tracheal mucosa, in thyroid cancer, invasion begins outside the airway and progresses toward the lumen, making it difficult to …
The treatment plan for thyroid cancer is determined based on the site, depth, and extent of the invasion. Different from tumours arising …
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma.
Nagao Y, Yokoi A, Yoshida K, Sugiyama M, Watanabe E, Nakamura K, Kitagawa M, Asano-Inami E, Koya Y, Yoshihara M, Tamauchi S, Shimizu Y, Ikeda Y, Yoshikawa N, Kato T, Yamamoto Y, Kajiyama H. Nagao Y, et al. Among authors: ikeda y. Pharmacol Res. 2023 Mar;189:106693. doi: 10.1016/j.phrs.2023.106693. Epub 2023 Feb 10. Pharmacol Res. 2023. PMID: 36773710 Free article.
Uterine leiomyosarcoma (ULMS) is a malignant stromal tumor arising from the myometrium with a poor prognosis and very limited response to current chemotherapy. ...
Uterine leiomyosarcoma (ULMS) is a malignant stromal tumor arising from the myometrium with a poor prognosis and very limited respons …
Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
Ueda K, Ikeda K. Ueda K, et al. Among authors: ikeda k. Fukushima J Med Sci. 2024 Jan 27;70(1):11-24. doi: 10.5387/fms.2023-17. Epub 2023 Nov 11. Fukushima J Med Sci. 2024. PMID: 37952978 Free PMC article. Review.
Acute myeloid leukemia (AML) arises from preleukemic conditions. We have investigated the pathogenesis of typical preleukemia, myeloproliferative neoplasms, and clonal hematopoiesis. ...
Acute myeloid leukemia (AML) arises from preleukemic conditions. We have investigated the pathogenesis of typical preleukemia, myelop …
Adenocarcinoma arising in an adrenohepatic fusion-related cyst.
Kouchi Y, Takayashiki T, Harada S, Shinomiya Y, Nasu K, Ikeda JI, Ohtsuka M, Kishimoto T. Kouchi Y, et al. Among authors: ikeda ji. Pathol Int. 2022 Aug;72(8):426-429. doi: 10.1111/pin.13238. Epub 2022 Jun 13. Pathol Int. 2022. PMID: 35694849 No abstract available.
Familial adult myoclonus epilepsy: Neurophysiological investigations.
Dubbioso R, Suppa A, Tijssen MAJ, Ikeda A. Dubbioso R, et al. Among authors: ikeda a. Epilepsia. 2023 Jun;64 Suppl 1:S39-S46. doi: 10.1111/epi.17553. Epub 2023 Mar 8. Epilepsia. 2023. PMID: 36806000
After reviewing the diagnostic contribution of each neurophysiological technique, we discuss the possible mechanisms underlying cortical hyperexcitability and suggest the involvement of more complex circuits engaging cortical and subcortical structures, such as the cerebellum. We …
After reviewing the diagnostic contribution of each neurophysiological technique, we discuss the possible mechanisms underlying cortical hyp …
349 results